Kentucky Trust Company’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$329K Sell
7,710
-600
-7% -$26.8K 0.16% 93
2026
Q1
$400K Hold
8,310
0.21% 86
2025
Q4
$403K Sell
8,310
-630
-7% -$31.2K 0.21% 85
2025
Q3
$422K Hold
8,940
0.23% 84
2025
Q2
$432K Hold
8,940
0.25% 82
2025
Q1
$496K Sell
8,940
-105
-1% -$5.68K 0.29% 73
2024
Q4
$436K Buy
+9,045
New +$460K 0.26% 80

Other funds holding SNY

Kentucky Trust Company's SNY Position: Q2 2026 in Review

Kentucky Trust Company reduced its Sanofi (SNY) stake by 7.2% in Q2 2026, selling an estimated $26.8K and leaving 7,710 shares worth $329K. The position accounts for 0.16% of the portfolio, ranked #93.

Kentucky Trust Company first reported a position in SNY in Q4 2024 and has held it in 7 quarters since. The position peaked at $496K in Q1 2025. 181 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Kentucky Trust Company held 7,710 shares of Sanofi worth $329K as of Q2 2026.
  • Kentucky Trust Company sold 600 Sanofi shares in Q2 2026, an estimated $26.8K.
  • Sanofi made up 0.16% of Kentucky Trust Company's portfolio in Q2 2026, its #93 holding.
  • Kentucky Trust Company first reported a position in Sanofi in Q4 2024 and has held it in 7 quarters since.
  • Kentucky Trust Company's Sanofi position peaked at $496K in Q1 2025.
  • 181 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Kentucky Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.